Clinical characteristics of 82 cases of death from COVID-19Bicheng Zhang, Jun Wang, Xiaoyang Zhou et al.|PLoS ONE|2020Cited by 594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19Bicheng Zhang, Jun Wang, Fan Feng et al.|Frontiers in Molecular Biosciences|2020Cited by 497
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer TreatmentYuxiao Song, Bicheng Zhang, Yang Fu et al.|Frontiers in Immunology|2020Cited by 256
What is the optimal duration of immune checkpoint inhibitors in malignant tumors?Jiaxin Yin, Bicheng Zhang, Yuxiao Song et al.|Frontiers in Immunology|2022Cited by 36
Current status of the clinical use of PD-1/PD-L1 inhibitors: a questionnaire survey of oncologists in ChinaBicheng Zhang, Jun Wang, Yuxiao Song et al.|BMC Cancer|2020Cited by 23